Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2

Repositioning of histamine H1 receptor antagonist: Doxepin inhibits viropexis of SARS-CoV-2 Spike pseudovirus by blocking ACE2

(2021) Shuai Ge et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy

(2021) Amgad M. Rabie   MOLECULAR DIVERSITY

Oroxylin A is a severe acute respiratory syndrome coronavirus 2‐spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin‐converting enzyme II /cell membrane chromatography

(2021) Jiapan Gao et al.   PHYTOTHERAPY RESEARCH

Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays

(2021) Jingyou Yu et al.   JOURNAL OF VIROLOGY

Corilagin prevents SARS-CoV-2 infection by targeting RBD-ACE2 binding

(2021) Li Jun Yang et al.   PHYTOMEDICINE

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

(2021) Jordi Rodon et al.   Frontiers in Pharmacology

A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay

(2021) Gaetano Donofrio et al.   Vaccines

Novel 1,3,4-thiadiazole/oxadiazole-linked honokiol derivatives suppress cancer via inducing PI3K/Akt/mTOR-dependent autophagy

(2021) Ting Xu et al.   BIOORGANIC CHEMISTRY

Accelerated CDOCKER with GPUs, Parallel Simulated Annealing, and Fast Fourier Transforms

(2020) Xinqiang Ding et al.   Journal of Chemical Theory and Computation

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig

(2020) Changhai Lei et al.   Nature Communications

Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia (COVID-19): an empirical study from Wuhan, Hubei Province, China

(2020) Erdan Luo et al.   Chinese Medicine

Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial

(2020) Mingzhong Xiao et al.   PHARMACOLOGICAL RESEARCH

Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking

(2020) Xiaofeng Ruan et al.   Chinese Medicine

Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development

(2020) Sheng-Wen Huang et al.   Biomedical Journal

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus

(2020) Nan Wang et al.   PHYTOMEDICINE

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2

(2020) Yongjing Zhang et al.   VIROLOGY

Design and synthesis of new norfloxacin-1,3,4-oxadiazole hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)

(2019) Yong Guo et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Identification of 2-benzoxazolinone derivatives as lead against molecular targets of diabetic complications

(2018) Bhawna Vyas et al.   Chemical Biology & Drug Design

Honokiol, a Lignan Biphenol Derived from the Magnolia Tree, Inhibits Dengue Virus Type 2 Infection

(2015) Chih-Yeu Fang et al.   Viruses-Basel

Multiple effects of honokiol on the life cycle of hepatitis C virus

(2011) Keng-Hsin Lan et al.   LIVER INTERNATIONAL